GENAISSANCE PHARMACEUTICALS INC·4

Aug 11, 7:21 PM ET

Kalnik Matthew Walter 4

4 · GENAISSANCE PHARMACEUTICALS INC · Filed Aug 11, 2004

Insider Transaction Report

Form 4
Period: 2004-08-09
Kalnik Matthew Walter
Sr. V.P., Business Development
Transactions
  • Award

    Stock Option (Right to buy)

    2004-08-09$2.95/sh+175,000$516,075175,000 total
    Exercise: $2.95From: 2004-11-09Exp: 2004-08-08Common Stock (175,000 underlying)
Footnotes (1)
  • [F1]The option vests in equal quarterly installments over four years beginning three months after the date of grant.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -